On February 2, 2021 Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company developing and commercializing critical care drug products, reported that it will present at the upcoming Virtual Investor Conferences Small and Microcap Showcase on Thursday, February 4, 2021 (Press release, Citius Pharmaceuticals, FEB 2, 2021, View Source [SID1234574514]). Citius Chairman of the Board Leonard Mazur will present an update on the Company’s lead product candidate MinoLok, currently in Phase 3 trials, and an overview of three other active programs.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Date: Thursday, February 4, 2021
Time: 1:00 p.m. ET
Link: https://bit.ly/3brvZ8w

This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event. It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. Learn more about the event at www.virtualinvestorconferences.com.